Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
qHPV vaccine for cervical HSIL in HIV-infected women
NCT01928225Phase 2Completed
- Sponsor
- University of the Witwatersrand
- Start
- Sep 2014
- Primary completion
- Nov 2017
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of qHPV vaccine in High grade squamous intraepithelial lesion of the cervix (HSIL), sponsored by University of the Witwatersrand. Started Sep 2014; status: completed.
02
Drugs
qHPV vaccine
03
Conditions
High grade squamous intraepithelial lesion of the cervix (HSIL)
Beyond the preview
Go deeper on NCT01928225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01928225.